Laman UtamaINDGN • NSE
add
Indegene Ltd
Tutup sebelumnya
â‚ą640.90
Julat hari
â‚ą631.50 - â‚ą643.90
Julat tahun
â‚ą470.10 - â‚ą736.30
Permodalan pasaran
153.60B INR
Bilangan Purata
427.48K
Nisbah P/E
38.31
Hasil dividen
-
Pertukaran utama
NSE
Berita pasaran
GS
1.12%
0.35%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(INR) | Sep 2024info | Perubahan T/T |
---|---|---|
Hasil | 6.87B | 8.04% |
Perbelanjaan pengendalian | 5.80B | 8.55% |
Pendapatan bersih | 917.00J | 22.27% |
Margin untung bersih | 13.35 | 13.14% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 1.26B | 14.33% |
Kadar cukai berkesan | 26.11% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(INR) | Sep 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 14.67B | — |
Jumlah aset | 30.24B | — |
Jumlah liabiliti | 6.64B | — |
Jumlah ekuiti | 23.60B | — |
Syer tertunggak | 238.80J | — |
Harga kepada buku | 6.48 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 12.22% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(INR) | Sep 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 917.00J | 22.27% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
CEO
Diasaskan
1998
Tapak web
Pekerja
4,367